Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens

The world is experiencing an unprecedented global pandemic of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, Severe Acute Respiratory Syndrome-coronavirus-2 (SARS-CoV-2). Development of new vaccines and therapeutics are important to achieve long-term prevention and control of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Jayanthi, Bruno, Samantha, Eichberg, Michael, Jannat, Risat, Rudo, Sharon, VanRheenen, Susan, Coller, Beth-Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295741/
https://www.ncbi.nlm.nih.gov/pubmed/32566261
http://dx.doi.org/10.1038/s41541-020-0204-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295741/
https://www.ncbi.nlm.nih.gov/pubmed/32566261
http://dx.doi.org/10.1038/s41541-020-0204-7

Ejemplares similares